Home/Investors/Vanguard

Vanguard

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$105.6B

Focus Areas

9

Top Stage

Commercial

Investment Focus

Respiratory HIV Oncology Vaccines Immunology Infectious Diseases Genetic Diseases Autoimmune Diseases Rare Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
GSK plc	Commercial	$104.1B	Respiratory, HIV
Intellia Therapeutics	Phase 3	$1.5B	Genetic Diseases, Oncology

Frequent Co-Investors

BlackRock2 shared Public shareholders1 shared Institutional investors1 shared State Street1 shared EcoR1 Capital1 shared Other institutional and public shareholders1 shared Fidelity Management & Research Company1 shared Regeneron Pharmaceuticals1 shared